Professional Documents
Culture Documents
Material Dentistry English
Material Dentistry English
Structure of a lipoprotein
Maintaining the equilibrium of the internal environment for water and minerals
(Na+, K+, Cl-, HCO3-, Ca2+, Mg2+), including pH homeostasis, is very important for the
organism, because any disturbance might have serious effect on metabolic processes, and
in certain cases the disequilibrium can even lead to death.
The distribution of water and electrolytes in the human body
Water is the most abundant component of the living organisms. The human fetus in
the intrauterine life contains at first 95%, then 85% water, at birth this value is reduced to
82-72%, and the adults contain only 50-60% water in their body (the value is slightly
lower in women compared to men because of the differences in the fat tissue).
The metabolic processes take place in water environment, so the internal regulation
of the composition of fluid compartments is very important, which is a prerequisite for
life. Water is distributed into fluid compartments in the body, separated by biological
membranes.
Around 66% of the water in the body is located in the intracellular fluid
compartment, and 33% in the extracellular fluid compartment. Only 8% of the body's
water content is in the plasma.
The blood contains cellular elements (45%) and plasma (55%). The percentage of
the cellular elements from the whole blood is called hematocrit. A healthy adult body
contains around 5 l of blood.
The composition of the interstitial fluid is similar to that of the plasma, the only
significant difference is that proteins are replaced by chloride ions in the interstitium. The
intracellular fluid’s electrolyte composition is very different from that of blood plasma,
because the cells contain higher amounts of potassium, magnesium, phosphate and less
sodium and chloride.
From table 1. it can be stated that the major cation of the extracellular space is Na +
(plasma concentration is 135 - 150 mmol/l), while the main intracellular cation is K +
(plasma level is only 3.5 - 5 mmol/). The plasma concentration of the ions is called
ionogram. In the blood plasma Cl- is the most abundant anion (plasma concentration is
95-110 mmol/l).
The role of red blood cells and the lungs in maintaining the hydro-electrolytic
balance
In the extrapulmonary tissues where the partial pressure of carbon dioxide (pCO 2) is
high, the CO2 will diffuse from the extracellular space into the red blood cells, where it
forms carbonic acid reacting with water by a reaction catalyzed by carbonic anhydrase,
and carbonic acid dissociates to H+ and HCO3- ions. In case of high pCO 2,
oxyhemoglobin delivers oxygen and K+ ions, and takes over the protons from carbonic
acid. The HCO3- exits the erythrocytes and participates to the formation of alkaline
reserve.
In the lungs pO2 is high and pCO2 is low. In such circumstances, the hemoglobin
binds oxygen, releasing protons and potassium ions bound to it. The bicarbonate ions in
the red blood cells are combined with the protons, forming carbonic acid, which is
decomposed to CO2 and water by a reaction catalyzed by the carbonic anhydrase. The
CO2 leaves the lungs in the exhaled air. This transport of protons by the erythocytes is
called the Bohr effect. In summary, the red blood cells represent a triple transport system:
they deliver oxygen from the lungs to tissues, and transport protons and CO 2 from the
tissues to the lungs.
The clotting ability of the body prevents the blood loss in case of vessel injury.
Blood clot (thrombus) develops in case of the adhesion of platelets (aggregation), which
can seal the damaged blood vessel. The blood clotting includes: the vessel wall (vascular
component), platelets (cell components) and the clotting factors (humoral component).
The blood coagulation occurs in the following steps:
- The temporary contraction of the local vessel wall
- The formation of the white thrombus at the site of the injury
- The formation of stable fibrin network, which covers the damaged vessel walls
(red thrombus).
The role of the vessel wall in the blood clotting
The damaged vessel wall activates the cellular and humoral clotting mechanisms
(prothrombotic role) and participates in limiting the extent of the thrombus. The intact
vessel wall contributes to keep the liquid state of blood (antithrombotic role).
The vessel wall is composed of several layers: intima (inside), media, adventitia.
The intima consists of two parts: the endothelial cell layer, and the subendothelial
connective tissue underneath (it contains collagen fibers, which play an important role in
the blood clotting, and adhesive proteins, such as fibronectin.
The coagulation process
The formation of the white thrombus
Due to the damage of the endothelium cells, the subendothelial collagen fibers will
be in contact with the bloodstream. Platelets adhesion occurs directly to these collagen
fibers, and by the von Willebrand factor (a subendothelial glycoprotein having the role of
glue).
The platelets are activated by adhesion, and several enzymes are activated (eg.
phospholipase A2, which releases arachidonic acid from the membranes), platelets release
a number of mediators (thromboxane A2, epinephrine, ADP), which play a role in
maintaining the vasoconstriction and the activation of the surrounding platelets. The
activated platelets are able to interconnect with each other (aggregation), they can bind to
fibrinogen molecules, thus forming the white platelet thrombus, which does not solve the
problem of covering the vascular injury on long-term.
Aspirin, through inhibition of cyclooxygenase, plays a role in the prevention of
thrombosis (the enzyme cyclooxygenase catalyzes the synthesis of prostaglandins and
thromboxanes from arachidonic acid, they are among the many inflammatory mediators
and pro-aggregant substances). The enzyme cyclooxygenase is necessary for the TXA2
synthesis, which plays a role in the local vasoconstriction, platelet activation and
promotes platelet aggregation.
The formation of the fibrin clot
The fibrin clot contains a network of fibrin which includes cellular blood
components. It is a thick, resistant structure, that can effectively and permanently cover
the vascular injury. Platelet shrinking increases the resistance of the clot. This is called
the red thrombus, which is formed by a number of consecutive reactions, with the
assistance of several proteolytic enzymes.
The activation of coagulation factors are made by two pathways. The longer one is
the intrinsic pathway, which involves only elements present in the blood, and the shorter
one is the extrinsic pathway, which includes also external factors. The two pathways
differ in the first few steps, then they continue with the common pathway.
In the body under physiological conditions blood coagulation starts by the extrinsic
pathway, and then accelerates involving also the intrinsic pathway, but not the very first
steps. The first steps of the intrinsic pathway play a role in blood clotting under in vitro
conditions (eg. in test tubes), and it can be activated in the body under certain
pathological conditions.
The table 2 contains a list of the coagulation factors and cofactors.
As we can notice, there are in fact only 12 clotting factors, because factor VI. does
not exist. Most of the clotting factors are proenzymes of protein-degrading enzymes
called zymogens (factors II, VII, IX, X, XI, XII). Similarly to the pancreatic digestive
enzymes, they undergo a limited proteolysis cascade to become active, removing a part of
the substrate molecule, which inhibits the active center, so it is also activated. There are
also several cofactors (III, IV, V, VIII), which form activated complexes with some
proenzymes.
The extrinsic pathway
The tissue factor is an external factor, it can be found in most tissues, it is present in
large quantities in the brain, lung, placenta. Factor III. is missing from the membrane of
red blood cells and platelets, as they are in constant contact with the blood. In case of a
vascular injury, blood gets in contact with the adventitial cells, where this membrane
protein is located (connected to the membrane phospholipids). In the presence of Ca2+
ions it forms a complex with factor VIIa, which is activated by the traces of active factor
X present in the blood, factor III. has also an activating role on factor VII. Tissue factor
and VIIa forms a complex which activates factor IX., thus the intrinsic pathway is also
involved in the coagulation process.
The intrinsic pathway
The first step of this pathway is activated under physiological conditions only in
vitro, but in pathological cases, for example in septic shock bacterial endotoxins can
activate factor XII, so coagulation can take place without any vascular injury and may
develop very severe DIC (disseminated intravascular coagulation).
In the test tube, due to the contact with the glass surface, factor XII is activated, its
substrate is factor XI, proteolytic cleavage activates factor XI, and it transforms factor IX
into its active form. In the body factor XI. Is also activated by the thrombin generated by
the extrinsic pathway, thus accelerating the clotting process. The IXa factor forms a
complex with cofactor VIIIa (which is activated by thrombin), and this complex converts
factor X. into its active form. Here is the meeting point of the two pathways.
The genetic defect of factor VIII. causes hemophilia A, which is associated with
severe bleeding, because of the body's impaired ability to control blood clotting. This is
an unstable factor, so hemophilia A can be treated only with fresh plasma.
The deficiency of factor IX. causes hemophilia B or Christmas disease. Factor IX is
stable so hemophilia B can be treated with preserved blood.
The common pathway
The active factor X converts prothrombin to thrombin. This requires an activated
complex (similar to the previously described IXa-VIIIa complex). This complex consists
of the active factor Xa and cofactor Va (activated by the existing thrombin). Large
amount of thrombin is formed from prothrombin due to this activated complex.
Thrombin cleaves fibrinopeptides A and B (A from the chain and B from the
chain) from the fibrinogen molecules (which consist of , and chains). Thus are
removed amino acid sequences which helped the fibrinogen molecules to push each other
electrostatically. The resulting fibrin monomers can connect with each other in the middle
of the molecule by weak hydrophobic and electrostatic bonds. The venom of some snakes
exhibit thrombin-like effect by a substance named reptilase, it removes only one of these
fibrinopeptides.
The fibrin monomers bind together to form a soluble fibrin. This is not quite stable,
covalent bonds have to be formed to have a stable fibrin. For this purpose is necessary the
factor XIIIa, a transglutaminase, which is activated by thrombin. The transglutaminase
forms stable covalent bonds between the glutamine and lysine side chains of the fibrin
monomers (with NH3 elimination). Thus a three-dimensional network is formed,
containing the cellular elements. The platelets contain contractile proteins (like
actomyosin in the muscular tissue), their contraction shrinks the wound edges. Platelets
will have star-like shape as a result of the contraction.
The localization and regulation of blood coagulation
The coagulation should be limited at the place of the injury. The intact endothelial
cells contain a surface glycoprotein called thrombomodulin. When the thrombin binds to
the thrombomodulin, a change in the thrombin conformation occurs and this alters its
substrate specificity, it is not going to cleave fibrinogen molecules, instead it activates a
protease, the C protein, which inactivates factors Va and VIIIa, and promotes
antithrombin III effect on thrombin. Protein C also needs protein S for its full activation.
An alternative method to suspend the prothrombotic activity of thrombin is the
synthesis of antithrombins. Antithrombin I is fibrin itself: thrombin bound to it is
inactivated. Antithrombin II is 2-macroglobulin, from the platelets and from the liver, it
forms an irreversible complex with thrombin, inactivating it. Antithrombin III is the main
inactivator of thrombin, causing irreversible inactivation. It inactivates also other factors:
factors VIIa, IXa, Xa, XIa and XIIa. Antithrombin IV are the fibrin degradation products,
which inhibit the polymerization of fibrin.
The dilution of activated clotting factors in the bloodstream, the presence of serine
protease inhibitors also contribute to the localization of the process.
Heparin is the best in vivo and in vitro anticoagulant. The heparin promotes the
thrombin - antithrombin III reaction, and it can inhibit factor Xa and IXa as well. Heparin
is used in the acute phase of thromboembolic disease, after myocardial infarction for
prevention of thrombosis and treatment of DIC. Heparinized blood is used in
hemodialysis and extracorporeal circulation.
The antidote for heparin overdose is protamine sulfate. The monitoring of heparin
therapy is made with the activated partial thromboplastin time (APTT), which gives
information about the intrinsic pathway. A heparin-like substance is secreted in the saliva
of a blood-sucking parasite, Hirudo medicinalis, which also has anti-clotting effect.
The fibrinolysis
The aim of the fibrinolysis is to dissolve the clot. If the clot is too large, insoluble, it
is transformed into connective tissue. The main enzyme of the fibrinolysis is plasmin,
whose role is to break down the fibrin and clean up the clot after the wound is healed. Its
inactive proenzyme is plasminogen, plasminogen activators enhance the activation
process.
The plasmin proteolytically cleaves fibrin to fibrin degradation products - these can
be determined in the laboratory. The plasmin also inactivates factors Va and VIIIa.
Plasmin inhibitors are the main regulatory elements of fibrinolysis, they are necessary to
avoid too soon initiation of fibrinolysis.
Streptokinase and urokinase are drugs that promote the conversion of plasminogen
to plasmin. Streptokinase is used in emergency management of myocardial infarction,
pulmonary embolism and deep venous thrombosis. Thrombin time is used to evaluate the
efficacy of the treatment. Tissue plasminogen activator treatment is more efficient, but
more expensive in similar cases.
Antifibrinolytic substances, such as EACA (epsilon amino caproic acid) and
PAMBA (para-amino-methyl-benzoic acid) inhibit plasminogen binding to fibrin. They
are used in severe bleeding, but not in case of DIC. In DIC (disseminated intravascular
coagulation) trasylol (gordox) may be useful - this is a polypeptide extracted from calf
lungs, which has antiprotease effect, it inhibits trypsin and plasmin.
The role of calcium and vitamin K in the coagulation process
The Ca2+ ions play an important role in the coagulation process, with their electro-
positive charge they can bind to negatively charged intermediates, promoting the
formation of complexes, causing conformational changes in proteins. The sodium citrate,
sodium oxalate, EDTA-Na are used to inhibit blood clotting, because calcium is bound to
them. This effect is reversible because with addition of calcium the clotting process can
be started afterwards. Blood is taken in test tubes containing this kind of substances for
coagulation tests.
The decrease in calcium does not cause coagulation disorders, because the patient
dies of other consequences of hypocalcaemia before coagulation disorder develops.
Most of the clotting factors are produced in the liver, thus severe liver diseases lead
to coagulation disorders. Factors II, VII, IX and X suffer changes in the molecule after
synthesis. These factors include several glutamic acid radicals, which are carboxylated in
the presence of vitamin K, leading to the formation of gamma-carboxy glutamic acid
radicals, which are more negatively charged, and can bind calcium. In case of vitamin K
deficiency bleeding disorders occur because of improper carboxylation.
Vitamin K is a liposoluble vitamin. Vitamin K deficiency occurs when the bile duct
is obstructed by bile stones or pancreatic head cancer. Therapeutically antivitamins K are
often used as anti-coagulants (warfarin derivatives). Main indications are the treatment of
deep venous thrombosis (heparin is given at first, then coumarin derivatives), prevention
of thrombosis, prophylaxis of embolism after surgery and in patients having artificial
heart valves. In case of overdose bleeding occurs, in this case vitamin K 1
(phytomenadione) injections are administered. The prothrombin time (Quick time) is
used to monitor the efficacy of the treatment, it provides information regarding the
extrinsic coagulation pathway.
The clotting time is a global parameter that gives information about the entire
coagulation process (normal value: 3-5 minutes).
In the surgical practice haemostatic sponges are used, which are placed on the
surface of diffuse parenchymal bleeding. These are useful for the liver, spleen traumatic
lesions, or in case of partial organ resections.
The blood clotting disorders
The clotting reaction is a life-saving defense mechanism, any irregularity it’s a life
threatening situation. There are basically two types of coagulation disorders: the blood
does not clot, or the blood coagulation process takes place without any injury.
The absence or reduced clotting function can be the consequence of the deficiency
of any clotting factor or cofactor (including calcium, vitamin K, etc.), or can occur due to
a dysfunction of coagulation enzymes regulating the process, such as plasmin. In severe
liver diseases deficiency of fibrin or thrombin precursors can occur.
The hemophilia is a sex-linked, genetically inherited disease. This means that the
hemophilia gene, responsible for the development of the disease, is localized on the
human 23rd chromosomes, the sex chromosome X. It is known that in women both sex
chromosomes are X, this explains why women are usually carriers of this disease (in very
rare cases both X chromosomes are abnormal). Men having a defective X chromosome
(and a Y chromosome) develop hemophilia. Deficiency of factor VIII. or IX. can cause
hemophilia.
If the structure of factor V is abnormal, its active form becomes resistant to
activated protein C effects, and therefore does not stop the blood clotting process. This
mutation (a genetic change) was observed by researchers in Leiden, so this abnormal
clotting factor was named Leiden factor. A similar resistance to activated C protein can
also occur during pregnancy and in women taking contraceptive pills, this explains the
frequent thrombotic events in these cases.
The genetic studies revealed that the the gene of the C and protein S, synthesized in
the liver in the presence of vitamin K, is on a somatic chromosome, and the defect is
dominantly inherited. This means that symptoms can appear in case of one defective
gene, in heterozygous form, in other cases two defective genes are present (homozygous
state), which causes a very high risk of thrombosis, and clotting disorders can appear in
early childhood. It is not surprising that half of the otherwise unexplained juvenile
thrombosis cases have in the background this hereditary disorder.
The gene of antithrombin III is also on a somatic chromosome, the inheritance is
dominant. It inhibits the action of thrombin, but also inhibits the activity of clotting
factors IX., X, XI. and XII.. The coagulation disorder is caused by the reduced amount of
antithrombin III or its malfunction.
Thrombosis, in most cases, is due to some local disorder of the blood vessel
(inflammation, atherosclerosis, abnormally low blood flow), and this enhances the
formation of blood clots. Predisposing factors are also important, these include smoking,
long-term immobilization, pregnancy, varicose veins, rhythm disturbances, oral
contraceptives. A blood clot formed (thrombus) blocks the blood vessel. In some cases,
the thrombus can be dislocated, and blocks other, potentially vital blood vessels (in the
brain, lungs or heart), thereby causing an embolism.
In order to have a proper interaction between the cell and its environment it is
necessary for the cells to receive extracellular signals and to transmit them inside the cell
to trigger the cell's response mechanism. Such signals are hormones and
neurotransmitters.
The hormones are signals that regulate cell metabolism and physiological
parameters.
The hormonal effects are of three types:
- autocrine: a hormone producing cell expresses receptors for that hormone, this
effect plays a role in autoregulation;
- paracrine: the hormone receptors are on the surrounding cells;
- endocrine: the hormones secreted by endocrine cells is released in the blood, and
acts at receptors distant from their site of release;
- neuroendocrine: the neurohormones secreted by the hypothalamus regulate the
hormon synthesis of endocrine glands by acting on the hypophysis.
The endocrine cells occur diffusely or form endocrine glands. The composition of
the endocrine system includes: the pituitary, thyroid, parathyroid glads, the adrenal cortex
and and medulla, Langerhans islet cells in the pancreas, testes, ovaries and the APUD
system cells (amine precursor uptake and decarboxilation) of the digestive tract.
The hormones of the endocrine system play a multiple role:
- They maintain the homeostasis in the body (such as insulin and glucagon act on
blood glucose levels, it is held between 60 -100 mg/dl)
- Hormones help the body to adapt to external influences, for example the "fight or
flight", by adrenaline and noradrenaline secretion
- Hormones regulate several processes, including cycles (eg. sex hormones such as
androgens, estrogens, progestagens control the sexual differentiation and maturation
processes, female sex hormones control the menstrual cycle and pregnancy).
Signal transduction systems
The hormones affect cell metabolism in different ways. Their receptors can be
localized in the plasma membrane or they can act on intracellular receptors.
On the bases of their signal transduction system, hormones can be divided into
several subgroups.
The fat-soluble (lipophilic) hormone molecules can go through the cell membrane,
thus they can pass from the extracellular transport proteins to the intracellular receptor.
The complex formed undergoes a temperature-dependent (thermotropic) and mineral salt-
dependent (liotrop) activation, thereby changing the conformation and electric charge
distribution on the surface.
After the activation the complex binds to the chromatin, or more precisely to a
section of DNA that contains a HRE (hormone responsive element), thereby activating or
inhibiting specific gene expression. Thus, these hormones regulate the synthesis of
proteins that are encoded by the respective gene.
The hormones belonging to group II have peptide structure, their specific receptors
are located on the cell membrane. G proteins play an important role in the intracellular
signal transmission of these hormones. They activate or inhibit intracellular enzymes,
which catalyze the synthesis of a second messenger molecule. The second messengers
affect cell metabolism. Based on the nature of the hormonal signaling system, they can be
divided into the following subtypes: adenylate, guanylate, and inositol phospholipid-
tyrosine kinase system. Corresponding to those listed before, the second messengers are
cyclic AMP (cAMP), cyclic GMP (cGMP), inositol triphosphate (IP3) and diacylglycerol
(DAG).
In case of the adenylate system, binding of the hormone (H) to the receptor (Rs), the
hormone-receptor complex activates a G protein that stimulates the adenylate cyclase
enzyme activity. The latter catalyzes the synthesis of cAMP (cyclic adenosine
monophosphate), which is a second messenger, which may cause changes in some
intracellular enzyme activity. The G protein consist of three subunits: , és . If GDP
(guanosine diphosphate) is bound to the subunit, this protein does not activate the
cyclase enzyme. The cholera toxin inhibits GTP (guanosine triphosphate) hydrolysis,
which is leading to continuous activation of adenylate cyclase, so large amounts of cAMP
will be produced.
In the human body there are four major stimulating systems. The hypothalamic
neuron-hormones and their corresponding trophormones are as follows:
1). CRH (corticotropin-releasing hormone) stimulates the pituitary ACTH secretion.
ACTH (adrenocorticotropic hormone) promotes the production of steroid hormones,
especially at the level of the corticosuprarenal gland.
The ACTH is excreted together with other hormones - MSH, LPH (lipotropic
hormone), endorphins - within a polypeptide named proopiomelanocortin (POMC).
The background of the development of Cushing's disease is a primary ACTH-
secreting adenoma. Addison’s disease (adrenal insufficiency) is manifested by
melanodermia (hyperpigmentation of the skin), especially at the level of the scars, due to
the MSH from POMC.
2). The TRH (tireotropin releasing hormone) stimulates the pituitary TSH secretion.
The TSH (thyroid stimulating hormone, tireotropin) is a glycoprotein with dimeric
structure, which stimulates the synthesis of thyroid hormones (T4=thyroxine,
T3=triiodothyronine).
3). GnRH (gonadotropin releasing hormone, gonadoliberin) or LHRH (luteinizing
hormone releasing hormone) stimulates the secretion of FSH and LH at the pituitary
level. The GnRH hypersecretion in childhood leads to early puberty. Pseudocyesis occurs
in case of an excess production of GnRH, which is a psychoneurotic condition that occurs
in women who want children very badly. The symptoms of pregnancy (amenorrhea,
breast swelling, nausea, vomiting, weight gain) are present, but without a real pregnancy.
The decrease in GnRH secretion is much more common, with central
hypogonadism. Prolonged stress conditions (war, imprisonment) and can lead to
psychogenic amenorrhea, and weight loss can have the same consequence. The most
serious case of functional amenorrhea appears in patients suffering from anorexia
nervosa. It occurs in young girls who have bizarre ideas about nutrition and the human
body, so keep excessive slimming.
The FSH (follicle-stimulating hormone) controls the gametogenesis at the level of
the gonads. The LH (luteinizing hormone), or interstitial cell-stimulating hormone
(ICSH) stimulates the selection of sex hormones: estrogens (in women), androgens (in
male).
4). The GHRH (growth hormone releasing hormone) and GHRIH (GH release
inhibiting hormone), also known as somatostatin, control the GH secretion of the
pituitary gland. The GH (growth hormone, STH - somatotropic hormone, somatotropin)
stimulates the synthesis of growth factors (called somatomedines) in the liver, such as
IGF-1, also known as somatomedin C (insulin-like growth factor).
The oversecretion of GH, which is usually due to a pituitary tumor, causes
gigantism in infants (pathologically increased growth) and acromegaly in adults.
In case of GH deficiency the body is retained in the growth, dwarfism (nanism) is
developed. In this disorder, as opposed to thyroid dysfunction in children, the body’s
proportions are normal and also the mental ability.
Prolactin plays an important role in milk production. It is synthesized in the
lactortop cells of the anterior pituitary lobe. The number and size of these cells
significantly increase during lactation.
The secretion of prolactin is under permanent inhibition of dopamine. Prolactin
inhibits the release of GnRH, and thus the gonadotropins (LH, FSH) secretion. The high
prolactin levels during lactation exhibit an inhibiting effects on the gonads (nursing
mothers have no menstrual cycle and no fertility). The pathological oversecretion of
prolactin can lead to sterility, which can be treated with dopamine agonists
(bromocriptine).
Pituitary insufficiency (panhypopituitarism) may occur in case of a non-secreting
pituitary adenoma, trauma, inflammation, or because of the pressure exhibited on the
pituitary gland by adjacent tumors. A special case is the Sheehan syndrome, which is due
to the necrosis of the pituitary gland, the cause is the great loss of blood during delivery,
which leads to contraction of blood vessels of the pituitary gland.
Oxytocin and vasopressin (antidiuretic hormone, ADH) are secreted in the
hypothalamus and transported to the neurohypophysis.
Oxytocin plays an important role in the contraction of the uterus during delivery
and in the ejection of milk.
The main role of antidiuretic hormone is to enhance water retention in the kidneys
by promoting resorption. Diabetes insipidus occurs in case of deficent ADH secretion.
The patients eliminate very large amounts of urine (3-20 l) called polyuria, the urinary
density is very low and the loss of excessive amounts of liquids lead to secondary
polydipsia (high water intake).
The testes
The testicular function is under the influence of the gonadotropin hormones. FSH
stimulates the sperm production, while LH (ICSH) enhances the production of
testosterone. The production of gonadotrophins has a constant level, because of the
negative feedback exhibited by testosterone.
Testosterone is a hormone essential for the function of male internal and external
genital organs, it is necessary for the development and maintenance of the male
secondary sexual characteristics. Testosterone can be transformed into estradiol.
Testosterone has an anabolic effect: promotes the protein synthesis, the ossification
and increase the erythropoiesis in the bone marrow (men have higher hemoglobin and
hematocrit values). The anabolic steroids (decanofort) are drugs which have reduced
androgenic effect, so are used in the treatment of osteoporosis, in cachectic states, anemia
due to bone marrow hypoplasia, etc..
BIOCHEMISTRY OF DIGESTION
The pancreas
Several digestive enzymes are produced in the pancreas and a fluid rich in HCO3-
which neutralizes the gastric acidity, this fulfills the neutralization of the gastric juice to
achieve an alkaline environment, necessary for the digestive enzymes in the intestinal
tract. Some enzymes such as amylase, lipase, ribo-and deoxyribonuclease are secreted in
active form, while others are inactive in the pancreas (zymogens such as trypsinogen,
chymotrypsinogen, proelastase, procarboxypeptidase, prophospholipase). To prevent the
premature activation of the zymogens in the pancreas, numerous regulatory molecules are
secreted (such as pancreatic trypsin inhibitor).
Under physiological conditions the zymogens are activated only in the duodenum.
The trypsinogen is activated to trypsin by an enteropeptidase produced by the lining of
the duodenum. Trypsin is a protease enzyme that has autocatalytic activity (it can activate
trypsinogen molecules), and it also activates other proteases by cleaving specific peptide
bonds. The human body contains several proteolytic (protein degrading) enzymes, as
each cleaves the peptide bond next to different aminoacid residues: trypsin cleaves near
basic amino acids (such as lysine), chymotrypsin cleaves the chain near aromatic amino
acids (such as tryptophan), while elastase cleaves the peptide bonds adjacent to small,
non-polar radicals (such as alanine). After eating food that is hard to digest, it is
recommended to take tablets containing digestive enzymes (such as triferment,
containing trypsin, lipase and amylase) and bile acids (bilagit). Some products contain
both pancreatic enzymes and bile acids (zymogen).
Under pathological conditions such as trauma or inflammatory diseases (acute
pancreatitis) zymogens are activated early, in the pancreatic tissue, leading to the
digestion of the pancreas (pancreatic necrosis), which has a very bad prognosis. In these
cases the high blood levels of pancreatic amylase and lipase can be detected. Trasylol is
an antiprotease drug that has been proven effective in the treatment of acute pancreatitis.
BIOCHEMISTRY OF NUTRITION
Anticontraceptive drugs are used for the prevention of not desired pregnancies, and
in polycystic ovarian syndrome
The side effects of the synthetic estrogens are: weight gain, retention of water, gall
bladder diseases, fibrocystic mastopathia, stroke, development of breast-, uterine- and
ovarian cancer, inducing autoimmun diseases, porphyria acute phase
Synthetic progestins protect from breast cancer, due to these components glucose
tolerance is lower, increased risk for thrombosis occurs, and depletion causes depression.
Under physiological conditions, the body produces estrogens and progesterone,
which exert their effect together. In fact, the cells need estrogens for the formation of
progesterone receptors, and progesterone contributes to the maintenance of normal
sensitivity in case of the estrogen receptors. As a result of this cooperation between the
sex hormones in the female body, the organism is normally protected from these negative
effects.
The synthetic progesterone derivatives compete with the natural ligand to occupy
the progesterone receptors, thus distrubing the effects of the natural hormone.